http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 712 reviews. 712 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Rowexetina

Choose a suitable interchangeable generic or brand drug, if you could not find the prescribed medicine.
We do not sell drugs. This site contains prices only for information purposes to help you buy drugs cheaply.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Rowexetina uses and description

Sort by popularity
Rowexetina - Used for: Treating premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome. It may also be used for other conditions as determined by your doctor.

Rowexetina is a selective serotonin reuptake inhibitor (SSRI). It works by restoring the balance of serotonin, a natural substance in the brain, which helps to improve mood.

Rowexetina is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina, an antidepressant agent belonging to the selective serotonin reuptake inhibitors (SSRIs), is used to treat depression, bulimia nervosa, premenstrual dysphoric disorder, panic disorder and post-traumatic stress. According to the amines hypothesis, a functional decrease in the activity of amines, such as serotonin and norepinephrine, would result in depression; a functional increase of the activity of these amines would result in mood elevation. Fluoxetine\'s effects are thought to be associated with the inhibition of 5HT receptor, which leads to an increase of serotonin level.

Rowexetina is used to treat depression. It can also be used to treat anxiety disorders such as panic disorder, social anxiety disorder, obsessive-compulsive disorder (OCD) or an eating disorder known as bulimia nervosa. Rowexetina may also be used together with other medicines to treat other depressive conditions as decided by your doctor. Rowexetina belongs to a group of antidepressants known as Selective Serotonin Re-uptake Inhibitors (SSRIs).

Oral Depression

Adult: 20-40 mg daily. Max: 80 mg daily.

Child: 8-18 yr: 10-20 mg daily; initiate at 10 mg daily for lower-wt children, may increase to 20 mg/day after 1 wk if necessary.

Elderly: Initially, 10 mg daily, may increase by 10-20 mg every few wk as tolerated. Max

Dosage: Hepatic impairment: Dose adjustments may be needed. Oral Bulimia nervosa

Adult: 60 mg daily. Hepatic impairment: Dose adjustments may be needed. Oral Obsessive compulsive disorder

Adult: Initially, 20 mg daily increased up to 60 mg daily after several wk if unresponsive. Max: 80 mg daily.

Child: 7-18 yr: Initially, 10 mg daily; may increase to 20 mg daily after 2 wk in adolescents and higher-wt children. Usual range: 10-60 mg daily. Hepatic impairment: Dose adjustments may be needed. Oral Premenstrual dysphoric disorder

Adult: 20 mg daily continuously. Alternatively, 20 mg daily, to be started 14 days before onset of menstruation and continue until 1st day of menses. May repeat with each cycle, if needed. Hepatic impairment: Dose adjustments may be needed. Oral Panic disorder

Adult: Initial dose: 10 mg daily, may increase to 20 mg daily after a wk. May increase to 60 mg daily after a few wk, if needed. Hepatic impairment: Dose adjustments may be needed.

Indications:

Adult: PO Depression 20-40 mg/day. Max: 80 mg/day. Bulimia nervosa 60 mg/day. Obsessive compulsive disorder Initial: 20 mg/day, up to 60 mg/day after several wk if unresponsive. Max: 80 mg/day. Premenstrual dysmorphic disorder 20 mg/day. Panic disorder Initial: 10 mg/day, up to 20 mg/day after a wk. Can further increase to 60 mg/day after a few wk if needed.

Rowexetina Alter is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Alter does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Ratiopharm is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Ratiopharm does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Recordati is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Recordati does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Merck is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Merck does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Actavis is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Actavis does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Aurobindo is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Aurobindo does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Genpharm is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Genpharm does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Pharm Association is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Pharm Association does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Hexal is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Hexal does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Hi Tech Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Hi Tech Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Mutual Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Mutual Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina ZIO Zdorovie is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina ZIO Zdorovie does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Biogaran is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Biogaran does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Nu-Pharm is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Nu-Pharm does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Almus is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Almus does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina EG Labo is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina EG Labo does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Pliva is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Pliva does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Alsi Pharma is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Alsi Pharma does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Obolenskoe Pharmaceutical Enterprise is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Obolenskoe Pharmaceutical Enterprise does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Mallinckrodt is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Mallinckrodt does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Ozon is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Ozon does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Lannacher Heilmittel is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Lannacher Heilmittel does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Dr. Reddy\'s Laboratories is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Dr. Reddy\'s Laboratories does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina G Gam Laboratoires is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina G Gam Laboratoires does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Morton Grove Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Morton Grove Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Teva is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Teva does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Qualimed Pharma is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Qualimed Pharma does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Zydus Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Zydus Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Wockhardt is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Wockhardt does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Carlsbad is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Carlsbad does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Watson Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Watson Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Pro Doc is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Pro Doc does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Barr Laboratories is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Barr Laboratories does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Eon Labs is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Eon Labs does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Cristers is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Cristers does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Lederle is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Lederle does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Novex is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Novex does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Canonpharma Production is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Canonpharma Production does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Pharmascience is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Pharmascience does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Sandoz is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Sandoz does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Discovery Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Discovery Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Mylan Pharmaceuticals is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Mylan Pharmaceuticals does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Ranbaxy is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Ranbaxy does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Alembic is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Alembic does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Sanofi-Aventis is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Sanofi-Aventis does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina IVAX is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina IVAX does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Arrow Generiques is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Arrow Generiques does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Alpharma is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Alpharma does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Alphapharm is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Alphapharm does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Siegfried, Sweden is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Siegfried, Sweden does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Rowexetina Medicines Production. Russia is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Rowexetina is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Rowexetina apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Rowexetina Medicines Production. Russia does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Active ingredients: Fluoxetine
Unit description, dosagePrice, USD

List of rowexetina brand and generic drugs

Rosal (Tunisia)
Rosal 100 mL x 1's$ 3.05
Rozax (Bahrain, Iraq, Jordan, Libya, Qatar, Saudi Arabia, Sudan, United Arab Emirates, Yemen)
S R B
S R B 20 mg Tablet$ 0.04
Salidep (India)
Salidep 40mg CAP / 100$ 0.79
Salidep 60mg CAP / 10$ 1.03
40 mg x 100's$ 0.79
60 mg x 10's$ 1.03
Salidep 40 mg Capsule$ 0.08
Salidep 60 mg Capsule$ 0.10
Salipax (Malta, Poland, Slovenia)
Salipax 20 mg x 30's
Capsules; Oral; Fluoxetine Hydrochloride 20 mg
Sandoz Fluoxetine (Canada, South Africa)
Capsule; Oral; Fluoxetine Hydrochloride 10 mg
Capsules; Oral; Fluoxetine Hydrochloride 10 mg
Sanzur
Sarafem (United States)
Capsule; Oral; Fluoxetine Hydrochloride 10 mg
Capsule; Oral; Fluoxetine Hydrochloride 20 mg
Tablet; Oral; Fluoxetine Hydrochloride 10 mg
Tablet; Oral; Fluoxetine Hydrochloride 15 mg
Tablet; Oral; Fluoxetine Hydrochloride 20 mg
Capsules; Oral; Fluoxetine Hydrochloride 10 mg
Capsules; Oral; Fluoxetine Hydrochloride 20 mg
Tablets; Oral; Fluoxetine Hydrochloride 10 mg
Tablets; Oral; Fluoxetine Hydrochloride 15 mg
Tablets; Oral; Fluoxetine Hydrochloride 20 mg
7 capsule in 1 blister pack
Sartuzin (Greece)
Saurat (Argentina)
Selectine (South Korea)
Selectus (Portugal)
Selfemra (United States)
Serezac
Serodep
Serodep 20 mg Capsule$ 0.09
Serol (Iceland)
Serol 20 mg
Seromex
Seronil (Finland, Poland)
Capsule; Oral; Fluoxetine Hydrochloride 20 mg
Seronil 20 mg x 30's
Seronil 20 mg x 100's
Capsules; Oral; Fluoxetine Hydrochloride 20 mg
Seroscand
Serotyl (Tunisia)
Siquial
Sofelin

Show all Rowexetina generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer